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Inflated False-Positive Rates in Hardy-Weinberg and
Linkage-Equilibrium Tests Are Due to Sampling on
the Basis of Rare Familial Phenotypes in Finite
Populations
To the Editor:
If it is assumed that genotypes of some locus (GD) are
in Hardy-Weinberg equilibrium (HWE) in a population
and that these genotypes are correlated with some phe-
notype (Ph), then, among “cases” in the tail of the dis-
tribution of Ph (equivalently, affected with rare dis-
ease), the GD will show Hardy-Weinberg disequilibrium
(HWD) (Nielsen et al. 1999; Deng et al. 2000; Go¨ring
and Terwilliger 2000). However, this does not imply that
“generally, in individuals at either end of the quantita-
tive-trait distribution, HWD exists if and only if there
exists a whole-population LD [i.e., “linkage disequilib-
rium”]” (Deng et al. 2000, p. 1030). The “only if” part
of this sentence is not correct. Even Deng et al. ( 2000,
p. 1044) point out that “an absence of HWD does not
imply that a marker locus and a QTL are not in LD”
and that, for completely random marker loci, there will
be inflated false-positive rates in tests for HWD (and LD
as well), because “cases” of familial disease tend to be
more related than “controls,” for the following reasons.
Assume that Ph is correlated in families, without spec-
ifying whether this is due to genetic or shared environ-
mental factors. Let the prevalence, f = P(individual B is
a case), and the familial relative risk l = P(individual B
is a caseFrelative A is a case)/f (Weiss et al. 1982; Risch
1990). Then, P(A and B are affectedFA and B are rel-
atives) = lf2, and P(A and B are affected ) = f2 if they
are randomly ascertained. This implies that P(A and B
are relativesFA and B are affected) = lf2P( A and B are
relatives)/f 2 = lP(A and B are relatives). If , thenl 1 1
ascertainment of “cases” ascertains relativeswith greater
probability than does random ascertainment of “con-
trols,” leading to increased false-positive evidence of
HWD and LD throughout the genome. This effect will
be largest when l is large, f is small, and the population
is small and/or structured (such that P[A and B are rel-
atives] is nontrivial). In a sense, this is related to the
problem of population stratification when the phenotype
being studied correlates with a familial stratum, regard-
less of whether the trait is “genetic” (see Chase 1977).
If the “case” phenotype is a good predictor of GD (a
prerequisite for mapping to be powerful), then a large
portion of the “case” sample will share some risk allele
IBD from some common ancestor. The coalescent path
connecting these chromosomes historically defines the
most distant possible relationship among the “cases”
carrying this allele, defining an upper bound on how
“unrelated” they could possibly be. Again, this implies
that ascertainment of affected individuals increases the
probability of ascertainment of relatives. And the less
frequent the shared risk allele is, the more closely related
the “case” individuals will be (see Terwilliger, in press),
leading to potential deviations from HWE and LE in
unrelated parts of the genome as well.
The more closely related two people are, the larger
the proportion of their genomes that they will share, as
measured by their kinship coefficient (also see Terwilli-
ger et al. 1997). If cases are “more related” than con-
trols, then they will, with higher probability than will
be seen in controls, share alleles IBD at random places
in the genome, leading to increased false-positive rates
in HWD and LD tests. This anticonservative behavior
may be minor in studies of a single marker locus, but,
when one considers the effects of testing hundreds of
thousands of markers jointly in a genome scan, often
making inferences based on the most significant values
of the test statistic over the genome, the inflation of the
type I error can have significant import. Furthermore,
because the effect of small deviations, from HWE and/
or LE, that are induced by such sampling is to shift the
distribution slightly upward, the anticonservative bias
will increase as we look farther out into the tail of the
pointwise distribution (data not shown—but similar in
shape to what appears in fig. 4 of Go¨ring and Terwilliger
2000), leading to potentially gross inflation of genome-
wide false-positive rates. To test for such problems, one
can do a Monte Carlo randomization, as was done, in
a case-control study of a small genetically homogeneous
population isolate, by Hovatta et al. (1999), who kept
the genotypes (for the whole genome scan) of all indi-
viduals constant and randomized their phenotypes
(“case” and “control”). The simulation showed that
their sample had approximately twice as many positives
as would be expected from the randomization test, con-
sistent with what is expected for reasons described in
this note. When the fundamental assumption that
“cases” and “controls” are independent and identically
distributed with respect to random marker-locus geno-
type frequencies throughout the genome appears to have
been rejected, it is essential to maintain skepticism in the
interpretation of the results of such an analysis.
Unfortunately, the conditions in which “cases” are
most likely to be relatives (e.g., small populations, rare
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diseases, large familial correlations) are the same cases
in which LD and HWD tests are likely to be useful (see
Zo¨llner and von Haeseler 2000; Terwilliger, in press). In
a study of more-common phenotypes and larger, more
diverse populations, it is highly unlikely that marginal
effects of single-risk alleles of a given locus are going to
be etiologically important—inwhich case, LD andHWD
tests will have little or no power (see Terwilliger and
Weiss 1998; Terwilliger and Go¨ring 2000; Weiss and
Terwilliger, in press). And small populations with unu-
sual histories are also more likely to have some popu-
lation-level deviation from HWE in general, and, if one
does not ascertain population controls, then there is no
way to validate this critical assumption of the model.
Although the paranoia about population stratification
that leads people to mistrust case-control samples may
be exaggerated, the absence of a sample of controls poses
even greater danger.
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QTL Fine Mapping, in Extreme Samples of Finite
Populations, for Complex Traits with Familial
Correlation Due to Polygenes
To the Editor:
Recently, Deng et al. (2000) developed a QTL fine-map-
ping approach on the basis of Hardy-Weinberg (HW)
or linkage-disequilibrium (LD) patterns in extreme sam-
ples of large and random-mating populations in which
HW equilibrium holds. This approach is based on robust
linkage results that have already localized a quantitative-
trait locus (QTL) to a large genomic region (e.g., ∼30
cM). The purpose is to fine map the QTL to a small
region of ∼1 cM, through examination of the patterns
of deviation fromHWand linkage equilibrium at a series
of closely linked marker loci in extreme samples of pop-
ulations. The deviation can be measured by a number
of indices (including some test statistics—e.g., the test
statistics for HW equilibrium) (Deng et al. 2000). Our
approach is an extension of those of Feder et al. (1996)
and Nielsen et al. (1998) for fine mapping of disease-
